Disparities in the gastrointestinal cancer burden across country income levels: a population-based study from 1990 to 2023
Gastrointestinal (GI) cancers represent a major global health burden. Socioeconomic context, approximated by country income level, is an important aggregate indicator associated with cancer outcomes and may reflect differences in risk factor exposure, healthcare access, and diagnostic capacity. This study aimed to comprehensively evaluate global patterns and trends in the incidence and mortality of GI cancers across the economic gradient. In this population-based study, data on six GI cancers (liver, colorectum, stomach, esophagus, pancreas, and gallbladder/biliary tract) were extracted from the Global Burden of Disease (GBD) 2023 study from 1990 to 2023. Countries were categorized into four World Bank income groups: high-income countries (HICs), upper-middle-income countries (UMICs), lower-middle-income countries (LMICs), and low-income countries (LICs). Primary metrics analyzed included age-standardized incidence rates (ASIR) and age-standardized death rates (ASDR). The burden of GI cancers showed distinct patterns across income levels. In 2023, LICs recorded the highest ASIR and ASDR for liver cancer, while HICs showed an increasing ASIR trend from 1990 to 2023, driven primarily by hepatitis C, alcohol consumption, and hepatitis B. The ASIR of colorectal cancer was highest in HICs; however, CRC mortality significantly declined in HICs, while ASDR increased in LMICs and LICs. The gastric cancer burden was highest in UMICs. Esophageal cancer exhibited an inverse relationship with country income level, with the highest ASIR and ASDR observed in LICs. Pancreatic and gallbladder cancers exhibited the highest ASIRs in HICs. Risk-attributable analysis revealed dietary risks as the leading contributor to GI cancer burden in HICs and LICs, while tobacco use predominated in UMICs and LMICs. Overall, this study reveals significant global inequalities in GI cancer burden across economic strata. LICs face a disproportionate mortality burden from highly fatal cancers such as liver and esophageal cancer, driven by high-risk exposure and limited care access. Conversely, HICs report high incidence rates for CRC and pancreatic cancer yet demonstrate notable mortality reductions in CRC, a benefit not yet realized in resource-limited settings. These income-stratified patterns represent associations and may reflect differences in risk exposure, diagnostic capacity, and health-system performance rather than income itself.
Authors
- Rong Lin (ORCID: https://orcid.org/0000-0002-7384-8841)
- Zenghong Wu
- Fangnan Xia
- Huili Ren
Institutions
- Wuhan No.1 Hospital (CN)
- Wuhan Union Hospital (CN)
- State Key Laboratory of Biocatalysis and Enzyme Engineering (CN)
- Huazhong University of Science and Technology (CN)
- Hubei University (CN)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s10020-026-01688-x
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00